Encompass Health Corp $ 79.58 0 (0%)
On watch
Volume:
391,732
Avg Vol (1m):
561,905
Market Cap $:
7.85 Bil
Enterprise Value $:
11.48 Bil
P/E (TTM):
24.87
P/B:
5.89
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.11 | ||
| Equity-to-Asset | 0.21 | ||
| Debt-to-Equity | 2.79 | ||
| Debt-to-EBITDA | 4.2 | ||
| Interest Coverage | 4.22 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 2.05 | ||
| Beneish M-Score | -2.67 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 14.18 | ||
| Net Margin % | 7.07 | ||
| ROE % | 24.42 | ||
| ROA % | 5.68 | ||
| ROC (Joel Greenblatt) % | 35.22 | ||
| 3-Year Revenue Growth Rate | 11.6 | ||
| 3-Year EBITDA Growth Rate | 7.8 | ||
| 3-Year EPS without NRI Growth Rate | 15 |
Valuation Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 24.79 | ||
| Forward PE Ratio | 21.83 | ||
| PE Ratio without NRI | 24.87 | ||
| Price-to-Owner-Earnings | 47.85 | ||
| PB Ratio | 5.89 | ||
| PS Ratio | 1.76 | ||
| Price-to-Free-Cash-Flow | 32.64 | ||
| Price-to-Operating-Cash-Flow | 13.26 | ||
| EV-to-EBIT | 17.08 | ||
| EV-to-EBITDA | 12.96 | ||
| EV-to-Revenue | 2.54 | ||
| PEG Ratio | 2.68 | ||
| Shiller PE Ratio | 23.48 | ||
| Current Ratio | 0.97 | ||
| Quick Ratio | 0.97 | ||
| Days Sales Outstanding | 41.77 | ||
| Days Payable | 223.5 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 1.4 | ||
| Dividend Payout Ratio | 0.34 | ||
| 3-Year Dividend Growth Rate | 5.7 | ||
| Forward Dividend Yield % | 1.4 | ||
| 5-Year Yield-on-Cost % | 3.33 | ||
| 3-Year Average Share Buyback Ratio | -3.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 1.23 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 2.32 | ||
| Price-to-Median-PS-Value | 1.39 | ||
| Price-to-Peter-Lynch-Fair-Value | 2.67 | ||
| Earnings Yield (Greenblatt) % | 5.85 | ||
| Forward Rate of Return (Yacktman) % | 14 |